Albion Capital Group LLP

Albion typically invests £2-5m for a minority stake Series A and early Series B. They support outstanding entrepreneurs who have demonstrated product-market fit, a clear go to market strategy and long term differentiation in a growth market. They look at most sectors, with a particular focus on digital B2B companies – enterprise software and technology services – across a broad range of sectors, including digital health, cybersecurity, martech and fintech. Companies that benefit from macro themes around disruption, digital transformation, and the trend towards a data-driven economy are particularly attractive. They also invest in companies commercialising IP from University College London via the UCL Technology Fund.

Valerie Aelbrecht

Investment Associate

Adam Chirkowski

Investment Director

Will Fraser-Allen

Managing Partner

Gigov, Emil

Partner

Molly Gilmartin

Investment Manager

David Gudgin

Partner

Sebastian Hunte

Investment Manager

Ed Lascelles

Partner

Tanel Ozdemir

Investment Manager

Kibriya Rahman

Investment Associate

115 past transactions

Pando

Seed Round in 2020
Pando is an essential tool for teamwork and secure collaboration. It is designed to benefit anyone working in health and social care, working in a team, with a need to share sensitive information and images securely.

Symetrica

Venture Round in 2019
Symetrica Ltd. engages in the development and commercialization of radiation detection and identification systems for security, medical diagnostics, geophysical, and space research and development applications. The company was incorporated in 2002 and is based in Southampton, the United Kingdom.

Pando

Seed Round in 2018
Pando is an essential tool for teamwork and secure collaboration. It is designed to benefit anyone working in health and social care, working in a team, with a need to share sensitive information and images securely.

Locum's Nest

Venture Round in 2018
Locum's Nest is an award-winning software platform connecting healthcare professionals to vacant work through innovative technology. The concept of Locum’s Nest originated from our Co-Founders, Dr Ahmed Shahrabani and Dr Nicholas Andreou, who had the determination and conviction to solve the staffing puzzle for professionals and organisations alike whilst they worked on the front line - as Junior Doctors. They experienced first-hand how hospitals and practices had to dedicate so much time in arranging cover to resource patient care, and not forgetting the drain it proved on precious, limited finances. We have a passion for best in class software engineering, with a team full of diverse talent, skills and expertise. To complement our product, we focus on long term partnerships with our customers, having a dedicated team on hand with a variety of NHS experiences. But, for any product to be truly effective, we must understand our app users and make it accessible. This requires a constant cycle of thinking, testing, building and learning.

Arecor

Venture Round in 2018
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

Phrasee

Series A in 2018
Phrasee is AI that specialises in language generation for marketing copy. Phrasee has developed a world-leading Natural Language Generation system, that can generate millions of human-sounding variants at the touch of a button. Phrasee’s tailored algorithms are created to target your customers, ensuring the copy Phrasee generates is on-point for your brand. The results? More opens, clicks, and conversions. Awesome. Having studied millions of words, phrases, and sentences, They’ve proven there is a science to human language. They designed Phrasee to use artificial intelligence to generate marketing language that outperforms humans. And it works – awesomely. Phrasee began as an idea in a pub in Camden Town, London, over a pale ale or three. Now it’s all over the internet. And is revolutionizing digital marketing, one sentence at a time.

Quantexa

Series B in 2018
Quantexa is a global data and analytics software company pioneering Contextual Decision Intelligence that empowers organizations to make trusted operational decisions by making data meaningful. The platform helps organizations protect, optimize, and grow by leveraging AI to unify siloed data, identify opportunities, and mitigate fraud. Using the latest advancements in big data and AI, Quantexa's platform uncovers hidden risks and new opportunities by providing a contextual, connected view of internal and external data in a single place.

Hazy

Seed Round in 2018
Data has never been more valuable. But with growing privacy demands and tightening regulations, most of the world’s data is locked away and unusable. For businesses to make better decisions, develop new technologies and deliver more value for customers, they need data they can actually use. They need to set their data free to do more. Hazy is pioneering the new data. We’re the world’s leading synthetic data company, re-engineering enterprise data so that it can be: - Shared without restrictions - data that can move freely, without restriction, to where it’s needed most in businesses and society - Used without limits - data that’s reliable, safe and easy for people and businesses to use to solve problems and create new value. - Trusted without question - data that’s open, transparent and trusted by people, businesses and society.

uMotif

Venture Round in 2018
UMotif is a scalable and engaging patient-centred data capture platform for modern research. The platform provides patient-facing technology to capture data for clinical research initiatives and also captures compliant, validated patient-generated e-consent, eCOA, ePRO, PROM, and PREM data for researchers and clinicians, allowing pharmaceutical companies to capture rich health data across a range of conditions.

Panaseer

Series A in 2018
Panaseer is the first Continuous Controls Monitoring platform for enterprise cybersecurity. Our platform shows you every asset, application, user and data set across your IT estate in real-time. This identifies gaps in controls coverage, aligns security with framework standards and substantiates regulatory compliance. Our automated reports significantly reduce reporting time and tailor insights to stakeholders at every level, enhancing decision-making from the boardroom to the analyst. These reports can also be mapped to the organisation’s structure, so you can prioritise risk based on impact to the business. Enterprise security leaders around the world trust our platform to help them make better security decisions.

Healios

Venture Round in 2018
Founded in 2013, Healios is a leading digital healthcare technology company working to empower patients and families affected by mental and physical illnesses.Healios is pioneering how family intervention and behavioural change techniques are delivered beyond treatment team walls, to maximise patient and family outcomes. By blending the best of technology, specialised expertise and a personal human connection, they help patients and families develop a new level of understanding and sustain healthier habits over time. Their mission is to transform how care is delivered to help patients, families and carers effectively move forward and achieve their goals, providing a better quality of life.

Hussle

Series A in 2018
Hussle provides fitness, marketplaces, online, digital, marketing, gym, advertising, and membership services. They also provide a network of gyms, pools, spas, and health fitness apps.

Koru Kids

Seed Round in 2018
Koru Kids is a building better childcare services, starting with nanny sharing in London. The team behind Koru Kids has a background in childcare (their own and other people's), healthcare and tech startups. Their company name is Koru Kids, company number is 10047637, and their HQ is 110 Hampstead Road, London, NW1 2LS. 'Koru Kids' is a registered trademark (UK00003153316). They are registered with the Information Commissioners' Office (registration number ZA181818), and also affiliated with the Financial Conduct Authority's Innovation Hub. They are grateful for the ongoing support (financial and moral!) of Camden Council.

Oviva

Series A in 2017
Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform. They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions. Oviva was founded in 2013 and is based in London, England.

G.Network

Venture Round in 2017
G.Network is the next generation communications service provider exclusively focused on Central London. The company provides affordable ultra-fast (up to 10Gbps) fibre connectivity to businesses. We are building our own ‘Fibre to the Premises’ (FTTP) fibre optic network directly into premises across the Capital meaning we can offer unrivalled quality and speeds at affordable prices. Bridging the gap between constrained copper-based connectivity and expensive, long lead time leased lines, G.Network ‘s fibre–based connectivity will transform the way you do business.

Panaseer

Seed Round in 2017
Panaseer is the first Continuous Controls Monitoring platform for enterprise cybersecurity. Our platform shows you every asset, application, user and data set across your IT estate in real-time. This identifies gaps in controls coverage, aligns security with framework standards and substantiates regulatory compliance. Our automated reports significantly reduce reporting time and tailor insights to stakeholders at every level, enhancing decision-making from the boardroom to the analyst. These reports can also be mapped to the organisation’s structure, so you can prioritise risk based on impact to the business. Enterprise security leaders around the world trust our platform to help them make better security decisions.

MPP Global

Series B in 2017
MPP Global delivers the only fully integrated cloud platform to identify, engage and monetise digital audiences. From metering and profiling to promotions, payments, subscriptions, and analytics, eSuite powers organisations to extract maximum value from their content and embrace monetisation opportunities prevalent in today's digital landscape. Founded in 2000, with offices throughout Europe, U.S., South America, and Australia, MPP Global has an impressive track record of helping companies create successful business models. Clients include Sky, The Times, McClatchy, The Football League, L'Equipe, Racing Post, Daily Mail, Local Media Group, New Zealand Herald, Debenhams, Philips and The Irish Times. For more information about MPP Global, please visit http://www.mppglobal.com

Quantexa

Series A in 2017
Quantexa is a global data and analytics software company pioneering Contextual Decision Intelligence that empowers organizations to make trusted operational decisions by making data meaningful. The platform helps organizations protect, optimize, and grow by leveraging AI to unify siloed data, identify opportunities, and mitigate fraud. Using the latest advancements in big data and AI, Quantexa's platform uncovers hidden risks and new opportunities by providing a contextual, connected view of internal and external data in a single place.

Convertr

Series A in 2016
Convertr is an API-first data optimization platform that acts as a firewall. We protect companies against expensive, bloated marketing databases overwhelmed by bad data. As a true SaaS platform, Convertr is not a lead or data provider. We are an unbiased tool, used to filter, enhance, normalize and automatically route compliant, accurate & actionable data to any number of endpoints.

SBD Automotive

Venture Round in 2016
Automotive Research & Consultancy, Connected Car Telematics, Vehicle Security, Autonomous Vehicles & ADAS, Analytical Reports, System Usability Testing, End User Surveys, Industry and Market Forecasts, Technical and Market Trends, Competitor Benchmarking

Achilles Therapeutics

Seed Round in 2016
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. The company's immunotherapies harness the immune system to destroy cancer cells that target truncal tumor neo-antigens and flags to the immune system present on the surface of every cancer cell, enabling scientists to target and destroy tumors without harming healthy tissues.

OLIM Investment Managers

Acquisition in 2016
OLIM is a specialist investment management company founded in 1986. OLIM is solely focused on fund management with no conflicting business interests. The investment team, consisting of Andrew Impey, Simon Jaffé and Angela Lascelles, manages UK equities and balanced portfolios. Julia Wills manages the OLIM office and works with Lynne Leath, our client account administrator, to ensure all clients receive the same, high quality, level of service.

Black Swan Data

Series B in 2016
Black Swan Data produces a social prediction SaaS platform. They use AI tech to curate various conversations into a framework for growth. The company uses AI, deep learning, and NLP techniques to transform this raw content into accessible predictive insight for subscribers.

Relayware

Venture Round in 2016
Relayware is a global provider of Partner Relationship Management (PRM) software and services that produce valuable insights and bring organizations closer to their partners, providing visibility into partner effectiveness, improving training and empowering partners to reach their potential. Its software distills years of channel expertise into an automated system that gives partners everything they need to succeed, with sales, marketing and training packs and partner portals that streamline revenue-generating processes and boost the productivity of indirect channels.

InCrowd Sports

Seed Round in 2016
InCrowd is a combination of three award winning, experienced and highly successful groups from three different sectors within sport, united in the aim to dramatically improve the in-stadia experience for fans, clubs and sponsors. A cutting edge technology solution was first created by the software engineers at the Sussex Innovation Centre led by Ian Wakeman, Jon Rimmer and Ciaran Fisher. Their solution allowed fans within stadiums to share information through a network which wasn’t reliant on multiple 3G/4G connections.

Grapeshot

Series C in 2016
Grapeshot (Acquired by Oracle) empowers the world’s leading brands and advertisers to bring relevance to every customer experience. With its proprietary Contextual Intelligence platform, Grapeshot transforms information into actionable data, and identifies revenue-driving behaviors. With solutions for predictive targeting, brand safety, and audience enrichment, advertisers, media agencies, programmatic platforms and publishers use power of Grapeshot to improve media efficiency, increase customer engagement and boost brand perception with their intended audiences. It has been named “Digiday’s Best Publisher Tool” and “Best Attribution Solution for Keyword Signal,” The Drum’s “Best Attribution Solution,” and the British Media Awards’ “Ad Provider of the Year,” among other honors. Grapeshot entered the market in 2006, and has offices in San Francisco, Los Angeles, Chicago, Toronto, New York, London, Cambridge, Singapore, Hong Kong, Shanghai and Sydney.

Innovation Broking

Venture Round in 2015
Innovation Broking is an independent commercial insurance broker. It provide corporate insurance broking services for companies and organisations seeking a knowledgeable and expert board level partnership.

Panaseer

Seed Round in 2015
Panaseer is the first Continuous Controls Monitoring platform for enterprise cybersecurity. Our platform shows you every asset, application, user and data set across your IT estate in real-time. This identifies gaps in controls coverage, aligns security with framework standards and substantiates regulatory compliance. Our automated reports significantly reduce reporting time and tailor insights to stakeholders at every level, enhancing decision-making from the boardroom to the analyst. These reports can also be mapped to the organisation’s structure, so you can prioritise risk based on impact to the business. Enterprise security leaders around the world trust our platform to help them make better security decisions.

Hussle

Series A in 2015
Hussle provides fitness, marketplaces, online, digital, marketing, gym, advertising, and membership services. They also provide a network of gyms, pools, spas, and health fitness apps.

Abcodia

Series B in 2015
Abcodia is a biotechnology company that focused on the discovery and validation of biomarkers for cancer screening. With its unique longitudinal serum biobank and partnerships with UCL, technology platform providers, and leading commercial diagnostic companies, Abcodia is able to support the end-to-end diagnostic development process. Abcodia was founded in 2010 and is based in Cambridge, UK.

Consensus

Seed Round in 2015
Consensus is a Software as a Service (SaaS) that automates custom product demos to accelerate sales. Their interactive demo platform personalizes videos and documents so each prospect automatically learns about the solution in the most relevant way.

Aridhia Informatics

Venture Round in 2014
Aridhia provides world leading biomedical informatics and analytic solutions to support stratified medicine and translational research, which will enhance understanding, diagnosis, prevention and treatment of chronic diseases. Aridhia believes that the integration and application of patient, clinical and genomic data represents a powerful opportunity to support clinical care across healthcare sectors, provide patients with the ability to take a more active role in their own care and provide information at a population level about disease trends, risk factors, impact of treatment and informed public health programmes. Working in close collaboration with experts in a clinical faculty model, Aridhia’s multidisciplinary team provides a unique combination of expertise to address one of the world’s most pressing health problems.

Exco InTouch

Venture Round in 2014
Exco InTouch focuses on the development of digital engagement and data capture solutions for clinical research and healthcare programs. Exco InTouch offers Gather, a system that enables clinical research providers gain data and improve patient engagement. The company also develops solutions that focus on patients’ long term condition management. Exco InTouch was founded in 2004 by Tim Davis. It is headquartered in Nottingham, England.

The Charnwood Pub

Venture Round in 2014
A collection of individual pubs from historic coaching inns with rooms to idyllic country pubs with roaring fires and delicious food. Unlike the majority of pubs today, Charnwood pubs are free houses without the burden of a tie to a brewery, brand or property landlord. This freedom enables us to tailor the offer of each of their pubs to their own community. They are committed to continually striving to improve each of their pubs and value any feedback from the communities they serve.

Mirada Medical

Venture Round in 2014
Mirada Medical is a prominent global brand in medical imaging software. Mirada’s innovative software solutions are routinely used in radiology, molecular imaging, radiation oncology and in multidisciplinary meetings throughout hospitals, imaging centers and cancer centers worldwide. Mirada excels at combining scientifically advanced technology with practical application for diagnosis, management and treatment of cancer and other diseases. - See more at: http://www.mirada-medical.com/about-mirada-medical/#sthash.Sp4rzAG0.dpuf

KERN Ventures

Venture Round in 2014
KERN Ventures is a venture building accelerator that provides pre-seed to seed funding and hands-on operational guidance to help initiate, co-create and accelerate startups. KERN Ventures primary goal is to create high-growth startups in key sectors such as on-demand services, fintech and e-commerce/online marketplaces. Twice a year, KERN Ventures invests in sets of five high-potential ideas and find the best talent to build the ideas with them.

Brandgility

Venture Round in 2014
The Brandgility Brand Asset Management (BAM) platform allows organizations to easily store and share brand assets and safely empower their workforce to build sales and marketing collateral with no-code, smart templates, and powerful creative automation tools that automatically comply with brand guidelines. Brandgility is a self-service solution designed to empower your workforce to own and streamline processes with the creation and maintenance of brand assets. With simple integrations available to ensure the cloud-based solution fits seamlessly into your organization. Trusted by some of the world’s leading brands Brandgility brings Brand Asset management to the forefront. Landing more relevant and engaging content across an expanding array of channels is driving big gains for savvy marketers. 30%-40%+ improvements in target outcomes, including customer acquisition, up-sales, registrations & referrals are not uncommon, along with improved brand affinity & loyalty. On the other hand, relevant, multi-channel engagement requires orders of magnitude more content. As a result, promising gains are too often obliterated by ballooning costs.

Chonais Holdings

Venture Round in 2014
Chonais Holdings is a renewable energy company based in London, United Kingdom.

Haemostatix

Venture Round in 2014
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Abcodia

Venture Round in 2014
Abcodia is a biotechnology company that focused on the discovery and validation of biomarkers for cancer screening. With its unique longitudinal serum biobank and partnerships with UCL, technology platform providers, and leading commercial diagnostic companies, Abcodia is able to support the end-to-end diagnostic development process. Abcodia was founded in 2010 and is based in Cambridge, UK.

MyMeds&Me

Venture Round in 2014
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry. The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.

DYSIS Medical

Venture Round in 2014
DYSIS Medical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical has developed a proprietary technology that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.

Green Highland Renewables

Venture Round in 2014
Green Highland Renewables (GHR) specialises in developing small scale run of river hydro projects from about 50kW to 2MW. GHR provides advice and solutions to landowners and communities through the whole process of design, procurement and operation and helps provide them with a sustainable future whilst supporting Scotland’s responsible commitment to climate change.

Perpetuum

Series C in 2014
Perpetuum Ltd. specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 and based in Southampton, United Kingdom, the company focuses on creating battery-free vibration energy harvesters and wireless sensor nodes for various applications, including rail, oil and gas, chemicals, power generation, and water treatment. Perpetuum's technology converts mechanical vibrations into electrical energy, enabling autonomous, maintenance-free wireless sensors that monitor equipment conditions and processes. This innovative approach enhances efficiency and safety in fleet management and services, particularly within the rail industry. As a technology spin-off from the University of Southampton, Perpetuum has established itself as a leader in vibration energy harvesting, providing practical solutions for wireless automation.

Relayware

Venture Round in 2014
Relayware is a global provider of Partner Relationship Management (PRM) software and services that produce valuable insights and bring organizations closer to their partners, providing visibility into partner effectiveness, improving training and empowering partners to reach their potential. Its software distills years of channel expertise into an automated system that gives partners everything they need to succeed, with sales, marketing and training packs and partner portals that streamline revenue-generating processes and boost the productivity of indirect channels.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

AMS Sciences

Seed Round in 2014
AMS Sciences specializes in providing advanced scientific solutions, particularly in the fields of healthcare and biotechnology

Taunton Nursing Home

Venture Round in 2014
Taunton Nursing Home is a non-profit healthcare facility that provides services for elders. Taunton Nursing Home provides short-term rehab services such as speech, occupational, and physical therapies. It provides ADL assistance as well as medication administration for its long-term residents. It also offers many other services, including social services; dental, podiatry, and vision care; chaplain services; and more. Taunton Nursing Home is based in Taunton, Massachusetts, United States.

Proveca

Venture Round in 2014
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit from a period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently. Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.

Chonais Holdings

Venture Round in 2014
Chonais Holdings is a renewable energy company based in London, United Kingdom.

Cisiv

Venture Round in 2014
Cisiv has been a pioneering developer of technology solutions for pharmaceutical companies, enabling customers to capture new levels of information on the use of their products and treatments in real world settings.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

OmPrompt

Venture Round in 2014
OmPrompt’s Order Management Platform provides EDI connectivity, non-EDI document automation, visibility and control solutions in order-to-cash and procure-to-pay processes. With one platform, suppliers can connect to any trading partner, automate any document and process any format.

Blackbay

Venture Round in 2014
Blackbay Ltd. develops and implements mobile enterprise solutions and services for supply chain and field service operations. It offers Delivery Connect, a mobile freight solution for real time job tracking; Service Connect, a business mobility solution that provides off-site service and parts ordering system with timesheets as well as provides vehicle cradles that hold handheld computer devices in vehicles. The company offers its products for use with handheld intelligent devices and the back-end infrastructure in postal, point to point courier, hub and spoke, third party logistics, service dispatch, social housing, facilities management, and manufacturing industries. Blackbay currently has over 55,000 mobile workers in the field worldwide. Customers include Royal Mail, Hermes, Dyson, DHL, DPD, Tyco, Chubb, Konica Minolta, Australia Post, Star Track Express and Capita. Blackbay Ltd. was formerly known as iTouch Business Mobility. The company was founded in 2004 and is headquartered in London, the United Kingdom. Blackbay Ltd. is a former subsidiary of iTouch plc.

Berkley Care Group

Venture Round in 2014
Berkley Care is an award-winning group of luxury care homes and with three of our five accredited homes being rated as 'Outstanding' by the CQC.

Active Lives Care

Venture Round in 2014
Active Lives Care was incorporated in 2013 and is based in London, United Kingdom.

Ryefield Court Care

Venture Round in 2014
Ryefield Court Care owns and operates a residential care home for elders. It was incorporated in 2012 and is based in Hillingdon, United Kingdom.

DYSIS Medical

Venture Round in 2014
DYSIS Medical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical has developed a proprietary technology that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.

Brandgility

Venture Round in 2014
The Brandgility Brand Asset Management (BAM) platform allows organizations to easily store and share brand assets and safely empower their workforce to build sales and marketing collateral with no-code, smart templates, and powerful creative automation tools that automatically comply with brand guidelines. Brandgility is a self-service solution designed to empower your workforce to own and streamline processes with the creation and maintenance of brand assets. With simple integrations available to ensure the cloud-based solution fits seamlessly into your organization. Trusted by some of the world’s leading brands Brandgility brings Brand Asset management to the forefront. Landing more relevant and engaging content across an expanding array of channels is driving big gains for savvy marketers. 30%-40%+ improvements in target outcomes, including customer acquisition, up-sales, registrations & referrals are not uncommon, along with improved brand affinity & loyalty. On the other hand, relevant, multi-channel engagement requires orders of magnitude more content. As a result, promising gains are too often obliterated by ballooning costs.

Green Highland Renewables

Venture Round in 2014
Green Highland Renewables (GHR) specialises in developing small scale run of river hydro projects from about 50kW to 2MW. GHR provides advice and solutions to landowners and communities through the whole process of design, procurement and operation and helps provide them with a sustainable future whilst supporting Scotland’s responsible commitment to climate change.

Gracewell Healthcare

Venture Round in 2014
Gracewell Healthcare is a residential care home company in the United Kingdom. Gracewell Healthcare Ltd. owns and operates a network of care homes in the United Kingdom. It offers a range of specialist and highly personalized care services in the areas of dementia and respite care, stroke rehabilitation, and nursing and personal care.

Mirada Medical

Venture Round in 2014
Mirada Medical is a prominent global brand in medical imaging software. Mirada’s innovative software solutions are routinely used in radiology, molecular imaging, radiation oncology and in multidisciplinary meetings throughout hospitals, imaging centers and cancer centers worldwide. Mirada excels at combining scientifically advanced technology with practical application for diagnosis, management and treatment of cancer and other diseases. - See more at: http://www.mirada-medical.com/about-mirada-medical/#sthash.Sp4rzAG0.dpuf

Bravo Inns

Venture Round in 2014
In TV soapland, pubs like the Rovers Return are at the very heart of their communities. In real life, the community pub is more important than that! Nothing defines a community better than its community pub. And at Bravo Inns Limited they’re committed to breathing life back into community pubs throughout their area. Based in Warrington and led by a small, dedicated and highly experienced management team, they now manage 35 community pubs in North Cheshire, Greater Manchester, Lancashire and Cumbria. Many were closed before they stepped in. Their success is due to strictly following a business model based on tried and tested core values. Take a tour though their site to discover more about Bravo Inns.

Grapeshot

Venture Round in 2014
Grapeshot (Acquired by Oracle) empowers the world’s leading brands and advertisers to bring relevance to every customer experience. With its proprietary Contextual Intelligence platform, Grapeshot transforms information into actionable data, and identifies revenue-driving behaviors. With solutions for predictive targeting, brand safety, and audience enrichment, advertisers, media agencies, programmatic platforms and publishers use power of Grapeshot to improve media efficiency, increase customer engagement and boost brand perception with their intended audiences. It has been named “Digiday’s Best Publisher Tool” and “Best Attribution Solution for Keyword Signal,” The Drum’s “Best Attribution Solution,” and the British Media Awards’ “Ad Provider of the Year,” among other honors. Grapeshot entered the market in 2006, and has offices in San Francisco, Los Angeles, Chicago, Toronto, New York, London, Cambridge, Singapore, Hong Kong, Shanghai and Sydney.

Hussle

Venture Round in 2014
Hussle provides fitness, marketplaces, online, digital, marketing, gym, advertising, and membership services. They also provide a network of gyms, pools, spas, and health fitness apps.

Silent Herdsman

Venture Round in 2014
Silent Herdsman’s vision is to be the leading global provider of predictive analytics software for dairy and beef farmers, that improves herd performance, business efficiency and animal welfare. Crucially, the collar triggers an alert to farmers when cows are on heat, providing farmers with advanced knowledge to activate insemination at critical times. This in turn enables them to produce more milk from the impregnated cows and increase their yields from each herd. The Silent Herdsman® triggers its alert via wireless technology to any mobile device such as a farmer’s mobile phone, tablet or laptop. Uniquely, its wireless technology can travel over long distances meaning it is suitable for farms hosting 100 to 20,000 cows. Its unique differentiator includes monitoring herds across large geographical distances on farms hosting several thousand beef or dairy cows.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Active Lives Care

Venture Round in 2014
Active Lives Care was incorporated in 2013 and is based in London, United Kingdom.

Egress Software

Series A in 2014
Egress is a software company that specializes in human layer security designed to prevent accidental and intentional data breaches. Its mission is to eliminate the greatest risk to every business the insider threat. To achieve this Egress has built the world’s only Human Layer Security platform that empowers your people to remain secure while being highly productive.

Haemostatix

Venture Round in 2014
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Street By Street Solar

Venture Round in 2014
Street By Street Solar offers rooftop solar installations with a sustainable source of power.

Abcodia

Venture Round in 2014
Abcodia is a biotechnology company that focused on the discovery and validation of biomarkers for cancer screening. With its unique longitudinal serum biobank and partnerships with UCL, technology platform providers, and leading commercial diagnostic companies, Abcodia is able to support the end-to-end diagnostic development process. Abcodia was founded in 2010 and is based in Cambridge, UK.

Mi-Pay

Post in 2014
Mi-Pay delivers outsourced payment solutions to digital e-commerce clients, primarily in the mobile sector. Its clientele is comprised of mobile operators, virtual operators, prepaid card providers, financial institutions, and media companies. The company also provides a portfolio of client branded, mobile payment services for mobile operators, financial service providers, utility companies, and media owners from their offices in the U.K., Romania, U.A.E., and India. Its infrastructure allows end customers to top-up using multiple payment methods such as credit or debit card, PaypalTM, bank transfer, and direct debit across all channels. Mi-Pay was founded in 2003.

Taunton Nursing Home

Venture Round in 2014
Taunton Nursing Home is a non-profit healthcare facility that provides services for elders. Taunton Nursing Home provides short-term rehab services such as speech, occupational, and physical therapies. It provides ADL assistance as well as medication administration for its long-term residents. It also offers many other services, including social services; dental, podiatry, and vision care; chaplain services; and more. Taunton Nursing Home is based in Taunton, Massachusetts, United States.

Green Highland Renewables

Venture Round in 2013
Green Highland Renewables (GHR) specialises in developing small scale run of river hydro projects from about 50kW to 2MW. GHR provides advice and solutions to landowners and communities through the whole process of design, procurement and operation and helps provide them with a sustainable future whilst supporting Scotland’s responsible commitment to climate change.

Cisiv

Venture Round in 2013
Cisiv has been a pioneering developer of technology solutions for pharmaceutical companies, enabling customers to capture new levels of information on the use of their products and treatments in real world settings.

Erin Solar

Venture Round in 2013
Erin Solar is a commercial solar panel management company. Erin Solar provide commercial landlords with solar photovoltaic solutions in Northern Ireland.

Relayware

Series A in 2013
Relayware is a global provider of Partner Relationship Management (PRM) software and services that produce valuable insights and bring organizations closer to their partners, providing visibility into partner effectiveness, improving training and empowering partners to reach their potential. Its software distills years of channel expertise into an automated system that gives partners everything they need to succeed, with sales, marketing and training packs and partner portals that streamline revenue-generating processes and boost the productivity of indirect channels.

Helveta

Venture Round in 2013
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

DYSIS Medical

Venture Round in 2013
DYSIS Medical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical has developed a proprietary technology that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.

MyMeds&Me

Venture Round in 2013
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry. The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.

Proveca

Venture Round in 2013
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit from a period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently. Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.

Hussle

Seed Round in 2013
Hussle provides fitness, marketplaces, online, digital, marketing, gym, advertising, and membership services. They also provide a network of gyms, pools, spas, and health fitness apps.

Haemostatix

Venture Round in 2012
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Xceleron Inc.

Venture Round in 2012
Xceleron believes that AMS technology and our expertise can get life-changing products quickly and cost-effectively to people who need them. We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.

Hilson Moran

Venture Round in 2012
Hilson Moran provides consultancy in building services, sustainability, facilities management and other services and is firmly established as a leading service engineer to commercial office, retail, leisure, hotel and residential projects.

Helveta

Venture Round in 2011
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Abcodia

Venture Round in 2011
Abcodia is a biotechnology company that focused on the discovery and validation of biomarkers for cancer screening. With its unique longitudinal serum biobank and partnerships with UCL, technology platform providers, and leading commercial diagnostic companies, Abcodia is able to support the end-to-end diagnostic development process. Abcodia was founded in 2010 and is based in Cambridge, UK.

Celoxica

Venture Round in 2011
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Radnor House School

Venture Round in 2010
Radnor House School is an independent school for boys and girls.

Masters Pharmaceutical Inc

Venture Round in 2010
Masters Pharmaceutical sources its drugs directly from the manufacturer, ensuring the quality pedigrees of its products as well as the prices. They provide catalogues, pricing, and unparalleled customer service. Their products include generic drugs, branded drugs, over-the-counter drugs, vaccines, and more.

Oxsensis

Series C in 2010
Oxsensis Ltd. manufactures optical sensors for pressure, vibration, temperature, and multiple parameters. The company offers optical instrumentation for precision controls in various environments, such as car and aero engines, as well as industrial, electrical, nuclear, and space applications. It also provides hi-temp optics, optical MEMS, fiber-optic assemblies, and packaging solutions. The company’s products comprise Wave-Phire Dynamic Pressure Transducer, which is used in harsh atmospheres, such as gas turbines and other combustion environments; i-Phire 4 Channel Optical Interrogator Unit that converts the optical signal into a voltage signal, which is directly proportional to the dynamic pressure; and S-Phire, a software for combustion monitoring. It serves energy production and emissions monitoring, transport, and high temperature equipment health monitoring markets. The company was incorporated in 2003 and is based in Didcot, the United Kingdom.

Orchard Portman House Hospital

Acquisition in 2010
Orchard Portman House Hospital is a mental health hospital and provides care and rehabilitative support of people.

Rostima

Venture Round in 2009
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Rostima

Seed Round in 2009
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Helveta

Funding Round in 2009
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Rostima

Venture Round in 2009
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Helveta

Venture Round in 2009
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Rostima

Venture Round in 2008
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Rostima

Venture Round in 2008
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.